GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Utah Medical Products Inc (NAS:UTMD) » Definitions » Piotroski F-Score

UTMD (Utah Medical Products) Piotroski F-Score : 6 (As of Dec. 14, 2024)


View and export this data going back to 1999. Start your Free Trial

What is Utah Medical Products Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Utah Medical Products has an F-score of 6 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Utah Medical Products's Piotroski F-Score or its related term are showing as below:

UTMD' s Piotroski F-Score Range Over the Past 10 Years
Min: 4   Med: 7   Max: 9
Current: 6

During the past 13 years, the highest Piotroski F-Score of Utah Medical Products was 9. The lowest was 4. And the median was 7.


Utah Medical Products Piotroski F-Score Historical Data

The historical data trend for Utah Medical Products's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Utah Medical Products Piotroski F-Score Chart

Utah Medical Products Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.00 6.00 7.00 7.00 5.00

Utah Medical Products Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.00 5.00 6.00 6.00 6.00

Competitive Comparison of Utah Medical Products's Piotroski F-Score

For the Medical Instruments & Supplies subindustry, Utah Medical Products's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Utah Medical Products's Piotroski F-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Utah Medical Products's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Utah Medical Products's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Sep24) TTM:Last Year (Sep23) TTM:
Net Income was 4.286 + 3.956 + 3.453 + 3.563 = $15.26 Mil.
Cash Flow from Operations was 5.332 + 5.276 + 2.762 + 3.856 = $17.23 Mil.
Revenue was 12.333 + 11.34 + 10.4 + 10.005 = $44.08 Mil.
Gross Profit was 7.098 + 6.766 + 6.253 + 5.802 = $25.92 Mil.
Average Total Assets from the begining of this year (Sep23)
to the end of this year (Sep24) was
(131.243 + 135.458 + 135.441 + 130.032 + 129.694) / 5 = $132.3736 Mil.
Total Assets at the begining of this year (Sep23) was $131.24 Mil.
Long-Term Debt & Capital Lease Obligation was $0.30 Mil.
Total Current Assets was $101.66 Mil.
Total Current Liabilities was $3.44 Mil.
Net Income was 4.555 + 4.214 + 4.2 + 3.935 = $16.90 Mil.

Revenue was 13.574 + 12.52 + 12.866 + 12.505 = $51.47 Mil.
Gross Profit was 8.327 + 7.843 + 7.739 + 7.359 = $31.27 Mil.
Average Total Assets from the begining of last year (Sep22)
to the end of last year (Sep23) was
(118.413 + 123.874 + 127.77 + 130.475 + 131.243) / 5 = $126.355 Mil.
Total Assets at the begining of last year (Sep22) was $118.41 Mil.
Long-Term Debt & Capital Lease Obligation was $0.31 Mil.
Total Current Assets was $101.85 Mil.
Total Current Liabilities was $4.18 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Utah Medical Products's current Net Income (TTM) was 15.26. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Utah Medical Products's current Cash Flow from Operations (TTM) was 17.23. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Sep23)
=15.258/131.243
=0.11625763

ROA (Last Year)=Net Income/Total Assets (Sep22)
=16.904/118.413
=0.1427546

Utah Medical Products's return on assets of this year was 0.11625763. Utah Medical Products's return on assets of last year was 0.1427546. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Utah Medical Products's current Net Income (TTM) was 15.26. Utah Medical Products's current Cash Flow from Operations (TTM) was 17.23. ==> 17.23 > 15.26 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Sep24)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Sep23 to Sep24
=0.299/132.3736
=0.00225876

Gearing (Last Year: Sep23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Sep22 to Sep23
=0.305/126.355
=0.00241383

Utah Medical Products's gearing of this year was 0.00225876. Utah Medical Products's gearing of last year was 0.00241383. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Sep24)=Total Current Assets/Total Current Liabilities
=101.656/3.435
=29.59417758

Current Ratio (Last Year: Sep23)=Total Current Assets/Total Current Liabilities
=101.847/4.177
=24.38281063

Utah Medical Products's current ratio of this year was 29.59417758. Utah Medical Products's current ratio of last year was 24.38281063. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Utah Medical Products's number of shares in issue this year was 3.478. Utah Medical Products's number of shares in issue last year was 3.639. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=25.919/44.078
=0.58802577

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=31.268/51.465
=0.60755853

Utah Medical Products's gross margin of this year was 0.58802577. Utah Medical Products's gross margin of last year was 0.60755853. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Sep23)
=44.078/131.243
=0.33585029

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Sep22)
=51.465/118.413
=0.43462289

Utah Medical Products's asset turnover of this year was 0.33585029. Utah Medical Products's asset turnover of last year was 0.43462289. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+0+1+1+1+1+0+0
=6

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Utah Medical Products has an F-score of 6 indicating the company's financial situation is typical for a stable company.

Utah Medical Products  (NAS:UTMD) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Utah Medical Products Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Utah Medical Products's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Utah Medical Products Business Description

Traded in Other Exchanges
Address
7043 South 300 West, Midvale, UT, USA, 84047
Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals as well as outpatient clinics and physicians offices.
Executives
Paul O Richins director, officer: VP, Treasurer, Asst. Secretary 7043 SOUTH 300 WEST, MIDVALE UT 84047
Barbara A Payne director
Ernst G Hoyer director
Kevin L Cornwell director, officer: Chairman, CEO, Secretary
Brian Koopman officer: Principal Financial Officer 108 E 1700 S, BOUNTIFUL UT 84010
James H Beeson director 7043 SOUTH 300 WEST, MIDVALE UT 84047
Greg A Leclaire officer: Chief Financial Officer 5225 WILEY POST WAY, SUITE 500, SALT LAKE CITY UT 84116
Stephen W Bennett director